Clinical trials
Phase 2 Urogenital Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xiaoxiang Chen | 2 |
| RenJi Hospital | 1 |
| Tianjin Medical University Second Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urogenital Neoplasms | 4 |
| Neoplasms | 3 |
| Adnexal Diseases | 2 |
| Carcinoma | 2 |
| Carcinoma, Ovarian Epithelial | 2 |
| Genital Diseases, Female | 2 |
| Genital Neoplasms, Female | 2 |
| Neoplasms by Histologic Type | 2 |
| Neoplasms by Site | 2 |
| Neoplasms, Glandular and Epithelial | 2 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.